Analystreport

Obalon Therapeutics Inc (NASDAQ: OBLN) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating.

OBALON THERAPEUTICS  (OBLN) 
Last obalon therapeutics earnings: 11/8 07:15 am Check Earnings Report
US:NASDAQ Investor Relations: investor.obalon.com